LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Nereus is focusing on the oceans and marine environments as a source of small-molecule compounds for the treatment of inflammation, cancer, and infectious diseases. Nereus utilized specialized research out of the Scripps Institution of Oceanography.
Nereus
San Diego, CA
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.